News Powered By:
– a collaborative partner.
CenterWatch : April 21, 2017 11:04 am : Centerwatch, Global News, King’s College, Plasticell, R&D Trends
Plasticell, a developer of cell therapies including hematopoietic cell replacement therapies, has partnered with King’s College London to progress preclinical trials of its artificial blood platelet product, manufactured from pluripotent stem cells. The work is supported by a MedCity research grant which funds collaboration between leading SMEs and academics from London universities. Over 10 million […]
The post Plasticell, Kings College London to collaborate in blood platelet substitute trials appeared first on CenterWatch News Online.
CenterWatch : April 20, 2017 1:34 pm : Awards & Advancement, Celgene, Centerwatch, Genentech, GlaxoSmithKline, Global News, Juno Therapeutics, Merck, Ultragenyx Pharmaceutical
Juno Therapeutics, a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, has appointed to its Board of Directors Dr. Rupert Vessey, president of Research and Early Development of Celgene. Dr. Vessey brings significant drug development capabilities to the Juno Board. Before joining Celgene in January 2015, Dr. Vessey was senior vice president […]
The post Juno appoints Rupert Vessey to board of directors, Sunil Agarwal President of R&D appeared first on CenterWatch News Online.
CenterWatch : April 20, 2017 1:17 pm : Awards & Advancement, Centerwatch, Global News, SynteractHCR
SynteractHCR, a full-service, international CRO, has appointed three new senior-level managers to its leadership team to ensure internationally-cohesive, enhanced support for sponsors. SynteractHCR’s newest senior executives include: Heather Davis, executive director of U.S. Project Management; Zia Haque, executive director, Clinical Data Management, and John Whitaker, Ph.D. as executive director, Biostatistics. All will report to Marlo […]
The post SynteractHCR adds three senior executives to management team appeared first on CenterWatch News Online.
CenterWatch : April 20, 2017 10:30 am : Centerwatch, CROs/Service Providers, Study Conduct, United States
Pharmaceutical Product Development (PPD) announced the kickoff of its 2017 educational campaign to raise awareness about the life-changing impact of clinical research, featuring a team of PPD Heroes who share their personal stories to inspire hope. PPD Heroes are extraordinary people who have overcome illness with medical treatments developed through clinical research. They help raise […]
The post PPD Heroes advocate for clinical research to improve patient health appeared first on CenterWatch News Online.
CenterWatch : April 20, 2017 10:27 am : Centerwatch, Drug Sponsors, Global News, Sawai Pharmaceutical, Upsher-Smith Laboratories
Sawai Pharmaceutical, a Japanese generic pharmaceuticals manufacturer, and Upsher-Smith Laboratories, a generics manufacturer based in Minnesota, U.S., have announced the signing of an agreement for Sawai to purchase the generic pharmaceuticals business of Upsher-Smith, from its parent, ACOVA. Upsher-Smith is a privately-held U.S. pharmaceutical company, owned by the Evenstad family through their company, ACOVA. Mark […]
The post Sawai Pharmaceutical to acquire Upsher-Smith Laboratories U.S. generics business appeared first on CenterWatch News Online.